Amgen Inc.
AMGN · Healthcare · · USDFahodi Score STRONG BUY Short-term (Swing)
81
/ 100
Technical
100
Trend & RS
92
Momentum
79
Fundamental (0%)
62
Macro
24
Liquidity
70
| Component | Score | Weight |
|---|---|---|
| Technical | 100.0 | 40% |
| Trend & RS | 92.3 | 20% |
| Momentum | 78.6 | 20% |
| Fundamental | 61.8 | 0% |
| Macro | 23.8 | 15% |
| Liquidity | 70.4 | 5% |
Trade Setup
| Entry | 450.39 |
| Stop Loss | 425.17 (5.6%) |
| Target 1 (1:1) | 475.61 (+5.6%) |
| Target 2 (2:1) | 500.83 (+11.2%) |
| ATR(14) | 12.61 (2.8%) |
| Risk per Share | 25.22 |
| Reward:Risk | 2:1 |
ATR-based levels. Adjust for support/resistance zones.
Factor Profile
| Factor | Score | Z | Bar |
|---|---|---|---|
| Value | 33.4 | -0.66 | |
| Momentum | 78.6 | +1.14 | |
| Quality | 65.4 | +0.62 | |
| Composite | 59.1 | ||
Quality Scores
Piotroski F-Score
5
/9 —
Average
✓
✓
✗
✗
✗
✗
✓
✓
✓
1. Positive Net Income
2. Positive Roa
3. Positive Cfo
4. Quality Earnings
5. Lower Leverage
6. Higher Liquidity
7. No Dilution
8. Higher Gross Margin
9. Higher Asset Turnover
Altman Z-Score
3.40
—
Safe Zone
Distress <1.81Grey 1.81–2.99>2.99 Safe
Valuation vs Peers Overvalued
| Metric | Stock | Sector | vs Peers |
|---|---|---|---|
| P/E Ratio | 26.7 | 22.0 | +21% above |
| P/B Ratio | 17.4 | 4.0 | Above |
| Dividend Yield | 2.2% | 1.5% | Above avg |
Comparing against Healthcare median multiples.
Trading at a premium to sector peers — verify growth justifies premium.
Intrinsic Value (DCF) Significantly Overvalued
Intrinsic Value
280.73
vs
Market Price
460.28
Upside
-39.0%
| Margin of Safety | -64.0% |
| Stage 1 PV (5yr FCF) | 36,812,405,625 |
| Terminal Value PV | 115,035,531,434 |
| Total Enterprise Value | 151,847,937,059 |
Assumptions
| Base FCF | 7,464,578,562 |
| Growth Rate (5yr) | 8.5% |
| Terminal Growth | 2.5% |
| Discount Rate (WACC) | 9.0% |
2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.
Position Sizing — Kelly Criterion
4.6%
Recommended Size
52.23%
Full Kelly
26.11%
Half Kelly
5.0%
Max Cap (Moderate)
Kelly inputs derived from quant score 81/100. Estimated win rate 64%, avg win 9.9%, avg loss 3.4%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.
RECOVERY
Regime: RECOVERY (40% confidence) — position size reduced 8%
Signal Summary STRONG BUY
4
Bullish Signals
0
Bearish Signals
54.76
RSI(14)
12.7572
MACD
Relative Strength (RS) IMPROVING
80
/ 99
RS Rating
✓ O'Neil PASS (≥80)
| RS vs SPY | ↑ RISING (+13.6% vs SPY 3M) |
| RS vs Sector | UNDERPERFORMING (Healthcare) |
| RS New High | No (2d since high) |
| Sector Outperformance | -2.4% (3M) |
RS Line — stock / SPY (90 bars)
← older
newer →
RS vs SPY
50-day SMA of RS
IMPROVING:
Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.
Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| Rsi | 54.76 | NEUTRAL |
| Macd | 12.7572 | BULLISH |
| Ma Cross | 422.23 / 375.22 | GOLDEN CROSS |
| Trend Short | ABOVE SMA50 | |
| Trend Long | ABOVE SMA200 | |
| Bollinger | MIDDLE | |
| Volume | 0.03x | LOW |
Key Levels
| Level | Price |
|---|---|
| 52-Week High | 483.99 |
| Bollinger Upper | 479.74 |
| SMA(200) | 375.22 |
| SMA(50) | 422.23 |
| SMA(20) | 444.94 |
| Current Price | 460.28 |
| Bollinger Lower | 410.14 |
| 52-Week Low | 312.39 |
| ATR(14) | 12.61 |
Advanced Technical Analysis
Click to expand
Wyckoff Phase & Volume Spread Analysis
Wyckoff Phase
Insufficient data for Wyckoff analysis.
Volume Spread Analysis (last 5 bars)
| Date | Signal | Vol | Description |
|---|---|---|---|
| 2026-11-02 | Normal | 1.17x | Normal bar — no special VSA pattern |
| 2026-11-03 | Normal | 0.88x | Normal bar — no special VSA pattern |
| 2026-11-04 | Normal | 1.7x | Normal bar — no special VSA pattern |
| 2026-11-05 | Normal | 1.51x | Normal bar — no special VSA pattern |
| 2026-11-06 | No Supply | 0.03x | Low volume, narrow spread, firm close — no selling pressure |
Ichimoku Cloud NEUTRAL
| Line | Value | Status |
|---|---|---|
| Tenkan-sen (9) | 461.63 | Above Kijun |
| Kijun-sen (26) | 440.00 | Base line |
| Senkou A | 450.82 | Leading span A |
| Senkou B | 429.23 | Leading span B |
| Cloud | 429.23 – 450.82 | Bullish (Green) |
| Price vs Cloud | 450.39 | Inside Cloud |
| Chikou Span | 403.04 | Bullish |
| Alignment Score | 3/4 | NEUTRAL |
TTM Squeeze & Divergences
TTM Squeeze
SQUEEZE OFF
No squeeze
Momentum:
BULLISH FADING
BB: 410.14 – 479.74 | KC: 426.62 – 463.26
Divergences (last 60 bars)
No significant divergences detected in the last 60 bars.
Anchored VWAP
VWAP: 363.72
Anchor: 2025-11-06 (52w Low)
ABOVE AVWAP
+23.8%
Heikin-Ashi Trend
WEAKLY BEARISH
Full data via /api/advanced/AMGN
Valuation
| Metric | Value |
|---|---|
| Market Cap | 248.97B |
| P/E (TTM) | 26.68 |
| Forward P/E | N/A |
| P/B | 17.35 |
| EPS | 17.25 |
Financial Health
| Metric | Value |
|---|---|
| Revenue Growth | 8.5% |
| Profit Margin | 24.1% |
| ROE | 78.4% |
| Debt/Equity | 376.30 |
| Current Ratio | 1.48 |
| Dividend Yield | 2.2% |
| Payout Ratio | N/A |
| Beta | 0.42 |
Trading Data
460.28
Open
460.28
Day High
460.28
Day Low
4.07M
Volume (1.5x avg)
Price Chart (90 Days)
Candlesticks (green=up, red=down)
SMA 20
SMA 50
Bollinger Bands (upper/lower)
Volume (green=buying, red=selling)